Pfizer Italia S.r.l.

Nerviano Medical Sciences S.r.l.

Pharmacia Italia S.p.a.

Francesco Angelucci

Maria Gabriella Brasca

Barbara Salom

William John Trigg

Edward Andrew Boyd

Frederick Arthur Brookfield

Jonathan Anthony Larard

Patrizia Giordano

Matteo D'anello

Katia Martina

Dania Tesei

Matteo D'Anello

Paolo Orsini

Maria Menichincheri

Ermes Vanotti

Anna Vulpetti

Raffaella Amici

Barbara Forte

Alessandra Cirla

Wolfgang Brill

William John Evotec Oai Trigg

Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them

Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors

Compounds which are indazole derivatives and pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them, as well as combinatorial libraries of indazole derivatives, as set forth in the specification, are disclosed; these compounds or compositions may be useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.

Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

Heteroarylpyrrolopyridinones active as kinase inhibitors

Compounds which are 3-aminoindazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.

Aminoindazole derivatives active as kinase inhibitors

Growing community of inventors

Novara, Italy

Katia Martina